Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
56
NCT02044861
Phase 1 Safety Study of ACT-PFK-158, 2HCl in Patients With Advanced Solid Malignancies
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 31, 2014
Completion: Not specified